Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles
Authors:
- 1 January 2010
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 57 (1) , 12-20
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY IMPROVES DETECTION AND RESECTION OF PAPILLARY BLADDER CANCER LESIONS AND REDUCES EARLY RECURRENCESJournal of Urology, 2009
- Molecular Pathogenesis and Diagnostics of Bladder CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: A microarray validation studyInternational Journal of Cancer, 2006
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinomaOncogene, 2005
- Prognostic Factors in Survival of Patients With Stage Ta and T1 Bladder Urothelial TumorsAmerican Journal of Clinical Pathology, 2004
- Prognostic Factors in Stage T1 Grade 3 Bladder Cancer Survival: The Role of G1–S Modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and Proliferation Index (ki67-MIB1)European Urology, 2004
- Hexyl Aminolevulinate Fluorescence Cystoscopy: A New Diagnostic Tool for Photodiagnosis of Superficial Bladder Cancer—A multicenter studyJournal of Urology, 2003
- ‘Superficial’ bladder cancer – time to uncouple pT1 tumours from pTa tumoursBJU International, 2002
- The Hallmarks of CancerCell, 2000